Harte Gold Corp.
Latest Comments

IntelGenx CEO speaks to the potential impact of Montelukast on Alzheimers

January 03, 2017
| January 03, 2017

In this InvestorIntel interview, Dr. Horst G. Zerbe, President and CEO of IntelGenx Technologies Corp. (TSXV: IGX | OTCQX: IGXT) […]

IntelGenx reports clinical progress on delivery of Alzheimer’s drug

August 23, 2016
| August 23, 2016 | 1 Comment

IntelGenx Corp. (TSXV: IGX | OTCQX: IGXT) announced that the absorption of montelukast sodium is increased by 52% when delivered […]

Aurora Solar Technologies Inc.